TREATMENT OF DERMATOPHYTE NAIL INFECTIONS - AN OPEN RANDOMIZED STUDY COMPARING INTERMITTENT TERBINAFINE THERAPY WITH CONTINUOUS TERBINAFINETREATMENT AND INTERMITTENT ITRACONAZOLE THERAPY
A. Tosti et al., TREATMENT OF DERMATOPHYTE NAIL INFECTIONS - AN OPEN RANDOMIZED STUDY COMPARING INTERMITTENT TERBINAFINE THERAPY WITH CONTINUOUS TERBINAFINETREATMENT AND INTERMITTENT ITRACONAZOLE THERAPY, Journal of the American Academy of Dermatology, 34(4), 1996, pp. 595-600
Background: Terbinafine persists in the nail at effective concentratio
ns for several weeks after discontinuation of treatment. Objective: Ou
r purpose was to verify whether intermittent terbinafine therapy is ef
fective in dermatophytic onychomycosis and to compare the results of i
ntermittent terbinafine with those of intermittent itraconazole and co
ntinuous terbinafine treatment. Methods: An open, randomized study of
63 patients was performed with three treatment regimens: terbinafine,
250 mg daily (21 patients); terbinafine, 500 mg daily for 1 week every
month (21 patients); or itraconazole, 400 mg daily for 1 week every m
onth (21 patients). Treatment was continued for 4 months in toenail in
fections (60 patients) and 2 months in fingernail infections (3 patien
ts). Results: At the end of the follow-up period (6 months after disco
ntinuation of treatment) 16 of 17 patients (94.1%) with toenail onycho
mycosis were mycologically cured in the terbinafine 250 mg group, 16 o
f 20 (80%) in the terbinafine 500 mg group, and 15 of 20 (75%) in the
itraconazole group. Conclusion: The percentage of patients who were my
cologically cured was higher in the continuous terbinafine group than
in the intermittent terbinafine and itraconazole groups, but statistic
al analysis did not reveal any significant difference between these cu
re rates.